Global Pharmaceuticals & Biotech Potentially Undervalued Companies

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Teva Pharmaceutical Industries

Market Cap: CHF 18.6b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Evolus

Market Cap: US$735.7m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Telix Pharmaceuticals

Market Cap: US$5.1b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

CSL

Market Cap: US$88.3b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Evotec

Market Cap: US$1.0b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Sarepta Therapeutics

Market Cap: US$2.0b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

TG Therapeutics

Market Cap: US$4.8b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Vanda Pharmaceuticals

Market Cap: US$295.5m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Bayer

Market Cap: US$29.8b

Operates as a life science company worldwide.

Halozyme Therapeutics

Market Cap: US$8.6b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Trulieve Cannabis

Market Cap: US$1.3b

Operates as a cannabis retailer.

Viatris

Market Cap: US$12.2b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Abeona Therapeutics

Market Cap: US$264.5m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Sarepta Therapeutics

Market Cap: US$2.0b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

ACADIA Pharmaceuticals

Market Cap: US$4.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Biogen

Market Cap: US$26.7b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Organon

Market Cap: US$2.0b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

WuXi Biologics (Cayman)

Market Cap: US$131.0b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Exelixis

Market Cap: US$11.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Amphastar Pharmaceuticals

Market Cap: US$1.3b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Merck KGaA

Market Cap: US$50.3b

Operates as a science and technology company in Germany and internationally.

Iovance Biotherapeutics

Market Cap: US$984.5m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Cresco Labs

Market Cap: US$475.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥17.0b

Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.

Solara Active Pharma Sciences

Market Cap: ₹25.0b

Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.

Zhejiang Medicine

Market Cap: CN¥13.3b

Manufactures and sells life nutrition and pharmaceutical products in China.

BeOne Medicines

Market Cap: HK$37.7b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Duality Biotherapeutics

Market Cap: HK$30.8b

A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

Medical Developments International

Market Cap: AU$56.3m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

Zhejiang Jingxin Pharmaceutical

Market Cap: CN¥16.1b

Zhejiang Jingxin Pharmaceutical Co., Ltd.

Pulike Biological Engineering

Market Cap: CN¥4.6b

Engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs.

Grand Pharmaceutical Group

Market Cap: HK$28.8b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥44.0b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

Solara Active Pharma Sciences

Market Cap: ₹25.0b

Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.

Chongqing Zhifei Biological Products

Market Cap: CN¥49.0b

Chongqing Zhifei Biological Products Co., Ltd.